CNGEX
Price
$81.13
Change
-$0.41 (-0.50%)
Updated
Sep 9 closing price
Net Assets
50B
RNPEX
Price
$74.15
Change
-$0.17 (-0.23%)
Updated
Sep 9 closing price
Net Assets
169.01B
Interact to see
Advertisement

CNGEX vs RNPEX

CNGEX vs RNPEX Comparison Chart in %
View a ticker or compare two or three
VS
CNGEX vs. RNPEX commentary
Sep 10, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNGEX is a Hold and RNPEX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNPEX has more cash in the bank: 169B vs. CNGEX (50B). RNPEX pays higher dividends than CNGEX: RNPEX (0.93) vs CNGEX (0.00). CNGEX was incepted earlier than RNPEX: CNGEX (25 years) vs RNPEX (24 years). CNGEX (1.00) is less costly to investors than RNPEX (0.75). CNGEX is a more actively managed with annual turnover of: 36.00 vs. RNPEX (23.00). CNGEX (250) and RNPEX (250) have matching initial minimum investment requirements. CNGEX annual gain was more profitable for investors over the last year : 18.30 vs. RNPEX (5.65). CNGEX return over 5 years is better than : 25.61 vs. RNPEX (11.06).
CNGEXRNPEXCNGEX / RNPEX
Total Expense Ratio1.000.75133%
Annual Report Gross Expense Ratio1.000.75133%
Fund Existence25 years24 years-
Gain YTD18.2837.215253%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets50B169B30%
Annual Yield % from dividends0.000.93-
Returns for 1 year18.305.65324%
Returns for 3 years63.8040.90156%
Returns for 5 years25.6111.06231%
Returns for 10 years129.89109.66118%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VWUSX76.65N/A
N/A
Vanguard US Growth Investor
FTDZX215.36N/A
N/A
Franklin Biotechnology Discovery Adv
PRJBX36.22N/A
N/A
PGIM Jennison Global Opportunities R2
ESCFX18.97N/A
N/A
1290 Essex Small Cap Growth A
CNWDX27.32-0.10
-0.36%
Calamos Evolving World Growth C